Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-06-08

Clinical Trial Update: Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating rosuvastatin's effect on triglyceride levels in Mexican patients with hypertriglyceridemia; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rosuvastatin (rosuvastatin)

Snippet

Sponsor: AstraZeneca | Conditions: Hypertriglyceridemia, Hyperlipoproteinemia Type IV | Phase 4 | Status: COMPLETED | Results posted: 2010-06-08